| Formatted contents note |
PART I ETHICS IN CLINICAL PRACTICE<br/>1 Bruce L. Miller (1981), 'Autonomy and the Refusal of Lifesaving Treatment',<br/>Hastings Center Report, 11, pp. 22-28.<br/>2 David Degrazia (1995), 'Value Theory and the Best Interests Standard', Bioethics, 9,<br/>pp. 50-61.<br/>3 Onora O'Neill (1984), 'Paternalism and Partial Autonomy', Jow/v/o/ ofMedical<br/>Ethics, 10, pp. 173-78.<br/>4 Steve Clarke and Justin Oakley (2004), 'Informed Consent and Surgeons'<br/>Performance', Journal of Medicine and Philosophy, 29, pp. 11-35.<br/>5 Robert M. Veatch (1972) 'Models for Ethical Medicine in a Revolutionaiy Age',<br/>Hastings Center Report, 2, pp. 5-7.<br/>6 John Hardwig (1990), 'What about the Family?', Hastings Center Report, 20,<br/>pp. 5-10.<br/>7 Rebecca Dresser (1995), 'Dworkin on Dementia: Elegant Theory, Questionable<br/>Policy', Hastings Center Report, 25, pp. 32-38.<br/>8 Norman Daniels (1986), 'Why Saying No to Patients in the United States is So<br/>Hard: Cost Containment, Justice, and Provider Autonomy', New England Journal<br/>ofMedicme,i' \A, pp. 1380-83.<br/>PART II ISSUES AT THE OUTSET OF LIFE<br/>9 Joseph Fletcher (1972), 'Indicators of Humanhood: A Tentative Profile of Man',<br/>Hastings Center Report, 2, pp. 1—4.<br/>10 Stephen Buckle (1988), 'Arguing fi"om Potential', Bioethics, 2, pp. 227-53.<br/>11 Jim Stone (1987), 'Why Potentiality Matters', Canadian Journal of Philosophy,<br/>17, pp. 815-30.<br/>12 Rosalind Hursthouse (1991), 'Virtue Theory and Abortion', Philosophy and<br/>Public Affairs, 20, pp. 223-46. ^ _<br/>13 Soren Holm (2002), 'G6irtg to the Roots of the Stem Cell Controversy',<br/>Bioethics, 16, pp. 493—507.<br/>14 John Harris (1997), "'Goodbye Dolly?" The Ethics of Human Cloning', Journal<br/>of Medical Efi'''-s, 23, pp. 353—60.<br/>PART III REPRODUCTIVE ETHICS<br/>15 Dena S. Davis (1997), 'Genetic Dilemmas and the Child's Right to an Open Future',<br/>Hastings Center Report, 27, pp. 7-15.<br/>16 Julian Savulescu (2001), 'Procreative Beneficence: Why We Should Select the Best<br/>Children'. Bioethics, 15, pp. 413-26.<br/>17 Michael J. Sandel (2004), 'The Case Against Perfection*, The Atlantic Monthly,<br/>293, pp. 51-62.<br/>18 Stephen Wilkinson (2003), 'The Exploitation Argument Against Commercial<br/>Surrogacy', Bioethics, 17, pp. 169-87.<br/>PART IV END-OF-LIFE ISSUES<br/>19 Peter Singer (1995), 'Presidential Address: Is the Sanctity of Life Ethic<br/>Terminally ill?', Bioethics, 9, pp. 327^3.<br/>20 Helga Kuhse (1984), 'A Modern Myth. That Letting Die is not the Intentional<br/>Causation of Death: Some Reflections on the Trial and Acquittal of Dr Leonard<br/>Arthur', Journal of Applied Philosophy, I, pp. 21 -38.<br/>21 Margaret Pabst Battin (2005), 'Euthanasia: The Way We Do it, the Way They<br/>Do It', in Margaret Pabst Battin, Ending Life: Ethics and the Way We Die,<br/>Oxford: Oxford University Press (US), pp. 47-68.<br/>22 George J. Annas (2005), '"Culture of Life" Politics at the Bedside - the Case of<br/>Terri Schiavo', New England Journal of Medicine, 352, pp. 1710-15.<br/>23 JeffMcMahan (1988), 'Death and the Value of Life", Ethics, 99, pp. 32-61.<br/>PART V PROFESSIONAL INTEGRITY AND THE GOALS OF MEDICINE<br/>24 Larry R. Churchill (1989), 'Reviving a Distinctive Medical Ethic', Hastings<br/>Center Report, 19, pp. 28-34.<br/>25 Leon R. Kass (1989), 'Neither for Love nor Money: Why Doctors must not Kill',<br/>The Public Interest, 94, pp. 25-46.<br/>26 Franklin G. Miller and Howard Brody (1995), 'Professional Integrity and<br/>Physician-Assisted Death', Hastings Center Report, 25, pp. 8-17.<br/>27 Jeffrey Blustein (1993), 'Doing What the Patient Orders; Maintaining Integrity in the<br/>Doctor-Patient Relationship', Bioethics, 1, pp. 289-314.<br/>PARTVI RESEARCH ETHICS<br/>28 Benjamin Freedman (1987), 'Equipoise and the Ethics of Clinical Research', New<br/>England Journal of Medicine, 317, pp. 141-45.<br/>29 Philip Pettit (1992), 'Instituting a Research Ethic: Chilling and Cautionary Tales',<br/>Bioethics, 6, pp. 89-1 12.<br/>30 Martin Wilkinson and Andrew Moore (1997), 'Inducement in Research', Bioethics,<br/>11, pp. 373-89.<br/>31 P. Lurie and S.M. Wolfe (1997), 'Unelhical Trials of Interventions to Reduce<br/>Perinatal Transmission of the Human Immunodeficiency Virus in Developing<br/>Countries', New EnglanclJoiirnal ofMedicine. 337, pp. 853-56.<br/>32 Participants in the 2001 Conference on Ethical Aspects of Research in<br/>Developing Countries (2004), 'Moral Standards for Research in Developing<br/>Countries: From "Reasonable Availability" to "Fair Benefits"', Hastings Center<br/>Report. 34. pp. 17-27.<br/>PART VII ETHICS AND THE PHARMACEUTICAL INDUSTRY<br/>33 Thomas W. Pogge (2005), 'Human Rights and Global Health: A Research<br/>Program', Mefaphilosophy, 36, pp. 182-209.<br/>34 A. Schafer (2004), 'Biomedical Conflicts of Interest: A Defence of the<br/>Sequestration Thesis - Learning from the Cases of Nancy Olivieri and<br/>David Healy', Journal of Medical Ethics, 30, pp. 8-24.<br/>35 Carl Elliott (2001), 'Pharma Buys a Conscience', American Prospect, 17,<br/>pp. 16-20.<br/>PART VIII BIOETHICS AND PUBLIC POLICY<br/>36 Daniel Wikler(1999), 'Can We Learn from EwgQmzsT ,Jottrnal of Medical Ethics,<br/>25, pp. 183-94.<br/>37 Judith Jarvis Thomson (1996), 'Abortion', Boston Review, 20, pp. 1-10.<br/>38 Mary Wamock (1987), 'Morality and the Law: Some Problems', Cambrian Law<br/>Review, 18, pp. 14-24.<br/>39 Amy Gutmann and Dennis Thompson (1997), 'Deliberating about Bioethics',<br/>Hastings Center Report, 27, pp. 38-41, |
